Aeterna Zentaris (AEZS) |
|
0.4899 -0.014 (-2.86%)
|
08-13 16:00 |
|
Open: |
0.4901 |
Pre. Close: |
0.5043 |
|
High:
|
0.4989 |
Low:
|
0.4702 |
|
Volume:
|
4,556,098 |
Market Cap:
|
31M |
|
|
|
|
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.501 - 0.504 |
0.504 - 0.506 |
|
Low:
|
0.463 - 0.467 |
0.467 - 0.47 |
|
Close:
|
0.485 - 0.491 |
0.491 - 0.495 |
|
Technical analysis |
as of: 2020-08-13 4:31:19 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 0.67 One year: 0.78 |
| Support: |
Support1: 0.46 Support2: 0.39 |
| Resistance: |
Resistance1: 0.57 Resistance2: 0.67 |
| Pivot: |
0.48 |
| Moving Average: |
MA(5): 0.51  MA(20): 0.48
MA(100): 0.75 MA(250): 0.97 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 57.76 %D(3): 68.95 |
| RSI: |
RSI(14): 44.66 |
| 52-week: |
High: 2.57 Low: 0.37 Change(%): -76.7 |
| Average Vol(K): |
3-Month: 420644 10-Days: 737460 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AEZS has closed below upper band by 42.3%. Bollinger Bands are 68.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to AEZS's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 14 Aug 2020
Aeterna Zentaris Inc. (AEZS) Stock Behavior Isn’t As Predictable As You Think - Stocks Register
Thu, 13 Aug 2020
Is Aeterna Zentaris Inc. (NASDAQ:AEZS), -414% away from high, Poised For A Strong Comeback? - Marketing Sentinel
Thu, 13 Aug 2020
Aeterna Zentaris Inc. (AEZS) is -26.71% away from 50-day simple Moving Average despite all headwinds - News Daemon
Mon, 10 Aug 2020
Here's Our Rant About Aeterna Zentaris Inc. (AEZS) - The News Heater
Mon, 10 Aug 2020
Aeterna Zentaris Inc. (NASDAQ:AEZS) Stock is Soaring, Here is Why - The Oracle Dispatch
Thu, 06 Aug 2020
Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
41 |
| Shares Float (M) |
21 |
|
% Held by Insiders
|
0.03 |
|
% Held by Institutions
|
10.82 |
|
Shares Short (K)
|
164 |
|
Shares Short P. Month (K)
|
100 |
Stock Financials |
|
EPS
|
-0.019 |
|
EPS Est This Year
|
-1.020 |
|
EPS Est Next Year
|
-0.290 |
|
Book Value (p.s.)
|
0.070 |
|
Profit Margin
|
-22.21 |
|
Operating Margin
|
-541.01 |
|
Return on Assets (ttm)
|
-25.5 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
2845.9 |
|
Gross Profit (p.s.)
|
0.003 |
|
Sales Per Share
|
0.038 |
|
EBITDA (p.s.)
|
-0.209 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-10 |
|
Levered Free Cash Flow (M)
|
-5 |
Stock Valuations |
|
PE Ratio
|
-25.78 |
|
PEG Ratio
|
|
|
Price to Book value
|
7.00 |
|
Price to Sales
|
12.75 |
|
Price to Cash Flow
|
-1.98 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
